“HPV vaccination in Honduras – lessons learned from a pilot program”
The school-based vaccination program was coordinated by Catholic Medical Mission Board with non-profit partners and was designed to successfully administer three doses to the target cohort. Key messaging campaigns educated healthcare workers, school teachers, principals, girls and their parents. Parents were given opt-out consent forms, and local media amplified the impact of community education and acceptance.
To date, 22,655 girls received dose #1, 16,385 girls received dose #2, and 6,080 received dose #3 with ongoing vaccination and data collection. More than 29,000 teachers, parents, and girls received educational program materials. To date, 298 healthcare workers were trained on vaccine administration and counseling, vaccine risks and benefits, data collection, and adverse events.
Despite challenges of labor strikes, gang violence, supply-chain management, and access to remote villages, local partners forged successful initiation of an HPV vaccination program. Recommend areas of improvement for future cohorts include: decrease loss-to-follow up by increasing communication to schools prior to vaccination days; integrate Ministry of Education employees with campaign; improve school census data prior to initiating vaccination; and create a transportation strategy for vaccination teams to visit schools.
Learning Areas:Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Protection of the public in relation to communicable diseases including prevention or control
Describe the successful implementation of HPV vaccination in Honduras, while assessing programmatic challenges to improve future cohorts.
Keyword(s): Adolescents, International, Cancer Prevention
Qualified on the content I am responsible for because: Country Director - CMMB Peru
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.